Arbutus Biopharma Corp Business Finance Contracts & Agreements
16 Contracts & Agreements
- Exchange Agreements (5 contracts)
- Purchase Agreements (1)
- Release Agreements (1)
- Repurchase Agreements (2)
- Share Agreements (2)
- Stock Agreements (2)
- Subscription Agreements (1)
- Trust Agreements (1)
- Underwriting Agreements (1)
- Subordination,Non-Disturbance and Attornment Agreement by and among, the Company, Univest Bank and Trust Co., and Veterans Circle Group, LLC dated December 12, 2023 (Filed With SEC on March 5, 2024)
- Form of Arbutus Biopharma Corporation Restricted Stock (Filed With SEC on March 2, 2023)
- Arbutus Biopharma Corporation 2020 Employee Stock Purchase Plan (Filed With SEC on June 1, 2020)
- Purchase and Sale Agreement, dated July 2, 2019, by and between Arbutus Biopharma Corporation and OCM IP Healthcare Portfolio LP (Filed With SEC on August 5, 2019)
- Master Contribution And Share Subscription Agreement: Genevant Sciences Ltd. dated April 11, 2018 (Filed With SEC on May 4, 2018)
- Roivant Sciences Ltd. Subscription Agreement for Preferred Shares (Filed With SEC on November 2, 2017)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on August 4, 2016)
- ARBUTUS BIOPHARMA 2011 OMNIBUS SHARE COMPENSATION PLAN (as approved by the board of directors on May 10, 2011 and approved by the shareholders at the June 22, 2011 Annual and... (Filed With SEC on August 4, 2016)
- Exhibit A Form of Release (Filed With SEC on May 4, 2016)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 9, 2016)
- SHARE REPURCHASE AGREEMENT (Filed With SEC on August 7, 2015)
- SHARE REPURCHASE AGREEMENT (Filed With SEC on August 7, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on May 6, 2015)
- 7,500,000 Common Shares TEKMIRA PHARMACEUTICALS CORPORATION (incorporated under the Business Corporations Act (British Columbia)) UNDERWRITING AGREEMENT (Filed With SEC on March 20, 2015)
- Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are... (Filed With SEC on March 13, 2015)
- Confidential treatment has been requestedfor portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions... (Filed With SEC on November 7, 2014)
